Cleveland BioLabs
CBLI
#9801
Rank
โ‚ฌ42.14 M
Marketcap
2,72ย โ‚ฌ
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Cleveland BioLabs (CBLI)

Last known market cap: โ‚ฌ42.14 Million

As of December 2025 Cleveland BioLabs has a market cap of โ‚ฌ42.14 Million. This makes Cleveland BioLabs the world's 9801th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cleveland BioLabs from 2006 to 2022

End of year Market Cap

Year Marketcap Change
2022โ‚ฌ45.74 M5.58%
2021โ‚ฌ43.32 M18.67%
2020โ‚ฌ36.5 M501.32%
2019โ‚ฌ6.07 M-39.13%
2018โ‚ฌ9.97 M-73.54%
2017โ‚ฌ37.69 M154.15%
2016โ‚ฌ14.83 M-57.71%
2015โ‚ฌ35.06 M161.81%
2014โ‚ฌ13.39 M-65.01%
2013โ‚ฌ38.27 M-14.89%
2012โ‚ฌ44.97 M-42.49%
2011โ‚ฌ78.2 M-50.25%
2010โ‚ฌ0.15 B236.77%
2009โ‚ฌ46.67 M123.69%
2008โ‚ฌ20.86 M-73.16%
2007โ‚ฌ77.74 M72.1%
2006โ‚ฌ45.17 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
โ‚ฌ17.95 M-57.40%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚ฌ0.91 B 2,067.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ152.57 B 361,926.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ217.80 B 516,707.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
โ‚ฌ91.18 B 216,261.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ103.84 B 246,289.98%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
โ‚ฌ83.93 B 199,048.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
โ‚ฌ13.94 M-66.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ777.90 B 1,845,699.95%๐Ÿ‡บ๐Ÿ‡ธ USA